The purpose of this scientific animation is to educate investors about SAFA (anti-Serum Albumin Fab Associated) technology and its potential as an effective protein delivery platform for treating cancer or inflammatory diseases. This animation highlights the versatility of the fusion protein called SAFAbody and its key mechanism of extending the half-life of the fused therapeutic proteins.